Molecular trajectories of remission in biologics therapy of IBD: private drug specific-signatures vs. common transcript modules

(1) IKMB-Institute of Clinical Molecular Biology Christian-Albrechts-University Kiel,Kiel,Germany

(2) IKMB + First Medical Department,Kiel,Germany

(3) Dep. of General Internal Medicine,Kiel,Germany

(4) Univers.-Klinik Schleswig-Holstein,Kiel,Germany

(5) Kiel University, University Hospital Schleswig-Holstein,Kiel,Germany

(6) Universität Kiel UKSH,Kiel,Germany



This item was part of the New ways to predict response in IBD session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019